MADRX | VIVIX | MADRX / VIVIX | |
Total Expense Ratio | 0.73 | 0.04 | 1,825% |
Annual Report Gross Expense Ratio | 0.73 | 0.04 | 1,825% |
Fund Existence | 3 years | 27 years | - |
Gain YTD | 2.318 | 1.452 | 160% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 5000000 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 119M | 189B | 0% |
Annual Yield % from dividends | 2.08 | 2.29 | 91% |
Returns for 1 year | -1.26 | 6.89 | -18% |
Returns for 3 years | -11.42 | 20.06 | -57% |
Returns for 5 years | N/A | 58.98 | - |
Returns for 10 years | N/A | 103.63 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NDMO | 10.13 | 0.04 | +0.40% |
Nuveen Dynamic Municipal Opportunities Fund | |||
NEA | 10.85 | 0.04 | +0.37% |
Nuveen AMT-Free Quality Municipal Income Fund | |||
HELX | 26.60 | 0.09 | +0.35% |
Franklin Genomic Advancements ETF | |||
FFND | 26.74 | -0.01 | -0.05% |
One Global ETF | |||
EDOW | 36.97 | -0.18 | -0.49% |
First Trust Dow 30 Equal Weight ETF |